Loading...
Repurposing of FDA -approved therapeutics to identify novel radiosensitisers in hypoxic prostate cancer.
Thiruthaneeswaran, N Bibby, B Yang, L McArt, D Choudhury, Ananya West, Catharine M L
Thiruthaneeswaran, N
Bibby, B
Yang, L
McArt, D
Choudhury, Ananya
West, Catharine M L
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018-03
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Repurposing of FDA -approved therapeutics to identify novel radiosensitisers in hypoxic prostate cancer. 2018, 30(3):195 Clinical Oncology